Asset Details
Do you wish to reserve the book?
Pharmacopoeias, Drug Regulation, and Empires
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pharmacopoeias, Drug Regulation, and Empires
Do you wish to request the book?
Pharmacopoeias, Drug Regulation, and Empires
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
eBook
Pharmacopoeias, Drug Regulation, and Empires
2024
Overview
The word \"pharmacopoeia\" has come to have many meanings,
although it is commonly understood to be a book describing approved
compositions and standards for drugs. In 1813 the Royal College of
Physicians of London considered a proposal to develop an imperial
British pharmacopoeia - at a time when separate official
pharmacopoeias existed for England, Scotland, and Ireland. A
unified British pharmacopoeia was published in 1864, and by 1914 it
was considered suitable for the whole Empire.
Pharmacopoeias, Drug Regulation, and Empires traces the
350-year development of officially sanctioned pharmacopoeias across
the British Empire, first from local to national pharmacopoeias,
and later to a standardized pharmacopoeia that would apply
throughout Britain's imperial world. The evolution of British
pharmacopoeias and the professionalization of medicine saw
developments including a transition from Galenic principles to germ
theory, and a shift from plant-based to chemical medicines. While
other colonial powers in Europe usually imposed metropolitan
pharmacopoeias across their colonies, Britain consulted with
practitioners throughout its Empire. As the scope of the
pharmacopoeia widened, the process of agreeing upon drug
standardization became more complex and fraught. A wide range of
issues was exposed, from bioprospecting and the inclusion of
indigenous medicines in pharmacopoeias, to adulteration and demands
for the substitution of pharmacopoeial drugs with locally available
ones.
Pharmacopoeias, Drug Regulation, and Empires uses the
evolution of an imperial pharmacopoeia in Britain as a vehicle for
exploring the hegemonic power of European colonial powers in the
medical field, and the meaning of pharmacopoeia more broadly.
Publisher
McGill-Queen's University Press
Subject
ISBN
9780228021049, 0228021049, 9780228021056, 0228021057
